BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34356895)

  • 1. IL-17A Damages the Blood-Retinal Barrier through Activating the Janus Kinase 1 Pathway.
    Byrne EM; Llorián-Salvador M; Tang M; Margariti A; Chen M; Xu H
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes.
    Byrne EM; Llorián-Salvador M; Lyons TJ; Chen M; Xu H
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.
    Scuderi S; D'Amico AG; Castorina A; Imbesi R; Carnazza ML; D'Agata V
    Peptides; 2013 Jan; 39():119-24. PubMed ID: 23220033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia.
    Nakamura N; Honjo M; Yamagishi R; Sakata R; Watanabe S; Aihara M
    Exp Eye Res; 2023 Dec; 237():109691. PubMed ID: 37884204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
    Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.
    Kuo C; Green CR; Rupenthal ID; Mugisho OO
    Acta Diabetol; 2020 Jan; 57(1):13-22. PubMed ID: 31030263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.
    Mesquida M; Drawnel F; Lait PJ; Copland DA; Stimpson ML; Llorenç V; Sainz de la Maza M; Adan A; Widmer G; Strassburger P; Fauser S; Dick AD; Lee RWJ; Molins B
    Transl Vis Sci Technol; 2019 Sep; 8(5):32. PubMed ID: 31667008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia increase tight-junction permeability in coordination with Müller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier.
    Inada M; Xu H; Takeuchi M; Ito M; Chen M
    Exp Eye Res; 2021 Apr; 205():108490. PubMed ID: 33607076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
    Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy.
    Jo DH; Yun JH; Cho CS; Kim JH; Kim JH; Cho CH
    Glia; 2019 Feb; 67(2):321-331. PubMed ID: 30444022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
    Luna JD; Chan CC; Derevjanik NL; Mahlow J; Chiu C; Peng B; Tobe T; Campochiaro PA; Vinores SA
    J Neurosci Res; 1997 Aug; 49(3):268-80. PubMed ID: 9260738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
    Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
    J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction.
    Coburn PS; Wiskur BJ; Miller FC; LaGrow AL; Astley RA; Elliott MH; Callegan MC
    PLoS One; 2016; 11(5):e0154560. PubMed ID: 27195776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-retinal barrier.
    Cunha-Vaz J; Bernardes R; Lobo C
    Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.
    Qiu AW; Liu QH; Wang JL
    Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
    van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
    Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.